Skip to content
DataLookout
Menu

IFLNDNCT06694116

Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar Cancer

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 3 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Nov 2026 to Dec 2029 Show 5 more changesShow less
    • Enrollment reopened
    • Eligibility criteria revised
    • Study completion pushed from Nov 2026 to Mar 2030
    • Site details revised
    • Publications: details revised at 5 of 5 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Detection rate of sentinel lymph node(s)
Timeframe: Two years
Sensitivity of sentinel lymph node mapping
Timeframe: Two years
Specifity of sentinel lymph node mapping
Timeframe: Two years
Negative and positive predictive values
Timeframe: Two years

Arms and interventions

Single arm study using carbon dye as a sentinel lymph node agent in early vulvar cancerExperimental

Single arm study using carbon dye as a sentinel lymph node agent in early vulvar cancer. Sterile charcoal carbon dye will be injected around vulvar tumor which will be searched in IFLND. No other arms.

Diagnostic tests: sentinel lymph node biopsy using carbon dye

Sites

1 site in 1 country

  • Istanbul University Med Fac Dept. of Obstet and Gynecol. Division of Gynecologic OncologyIstanbul, Turkey (Türkiye)